- Home
- DNP vs LNTH Comparison
DNP vs LNTH Comparison
Compare DNP & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNP
- LNTH
- Stock Information
- Founded
- DNP 1986
- LNTH 1956
- Country
- DNP United States
- LNTH United States
- Employees
- DNP N/A
- LNTH N/A
- Industry
- DNP Investment Managers
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- DNP Finance
- LNTH Health Care
- Exchange
- DNP Nasdaq
- LNTH Nasdaq
- Market Cap
- DNP 3.8B
- LNTH 3.8B
- IPO Year
- DNP N/A
- LNTH 2015
- Fundamental
- Price
- DNP $10.13
- LNTH $52.93
- Analyst Decision
- DNP
- LNTH Buy
- Analyst Count
- DNP 0
- LNTH 6
- Target Price
- DNP N/A
- LNTH $74.17
- AVG Volume (30 Days)
- DNP 479.6K
- LNTH 1.3M
- Earning Date
- DNP 01-01-0001
- LNTH 11-06-2025
- Dividend Yield
- DNP 7.88%
- LNTH N/A
- EPS Growth
- DNP N/A
- LNTH N/A
- EPS
- DNP 2.30
- LNTH 2.39
- Revenue
- DNP $154,887,179.00
- LNTH $1,525,933,000.00
- Revenue This Year
- DNP N/A
- LNTH N/A
- Revenue Next Year
- DNP N/A
- LNTH $1.98
- P/E Ratio
- DNP $4.26
- LNTH $22.15
- Revenue Growth
- DNP 3.30
- LNTH 1.95
- 52 Week Low
- DNP $8.69
- LNTH $47.25
- 52 Week High
- DNP $10.04
- LNTH $111.29
- Technical
- Relative Strength Index (RSI)
- DNP 52.48
- LNTH 44.38
- Support Level
- DNP $9.96
- LNTH $50.16
- Resistance Level
- DNP $10.22
- LNTH $55.55
- Average True Range (ATR)
- DNP 0.10
- LNTH 2.69
- MACD
- DNP -0.01
- LNTH -0.40
- Stochastic Oscillator
- DNP 62.24
- LNTH 24.18
About DNP DNP Select Income Fund Inc.
DNP Select Income Fund Inc is a closed-ended investment management fund. The primary investment objectives of the fund are current income and long-term growth of income. Its secondary objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing in the public utility industry.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.